International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(8), С. 7310 - 7310
Опубликована: Апрель 15, 2023
Autophagy
is
a
highly
conserved
intracellular
degradation
pathway
by
which
misfolded
proteins
or
damaged
organelles
are
delivered
in
double-membrane
vacuolar
vesicle
and
finally
degraded
lysosomes.
The
risk
of
colorectal
cancer
(CRC)
high,
there
growing
evidence
that
autophagy
plays
critical
role
regulating
the
initiation
metastasis
CRC;
however,
whether
promotes
suppresses
tumor
progression
still
controversial.
Many
natural
compounds
have
been
reported
to
exert
anticancer
effects
enhance
current
clinical
therapies
modulating
autophagy.
Here,
we
discuss
recent
advancements
molecular
mechanisms
CRC.
We
also
highlight
research
on
particularly
promising
modulators
for
CRC
treatment
with
evidence.
Overall,
this
review
illustrates
importance
provides
perspectives
these
regulators
as
new
therapeutic
candidates
drug
development.
ACS Omega,
Год журнала:
2023,
Номер
8(9), С. 8827 - 8845
Опубликована: Фев. 23, 2023
Compilation,
curation,
digitization,
and
exploration
of
the
phytochemical
space
Indian
medicinal
plants
can
expedite
ongoing
efforts
toward
natural
product
traditional
knowledge
based
drug
discovery.
To
this
end,
we
present
IMPPAT
2.0,
an
enhanced
expanded
database
compiling
manually
curated
information
on
4010
plants,
17,967
phytochemicals,
1095
therapeutic
uses.
Notably,
2.0
compiles
associations
at
level
plant
parts
provides
a
FAIR-compliant
nonredundant
in
silico
stereo-aware
library
phytochemicals
from
plants.
The
has
been
annotated
with
several
useful
properties
to
enable
easier
chemical
space.
We
have
also
filtered
subset
1335
drug-like
which
majority
no
similarity
existing
approved
drugs.
Using
cheminformatics,
characterized
molecular
complexity
scaffold
structural
diversity
performed
comparative
analysis
other
libraries.
Altogether,
is
extensive
atlas
that
accessible
https://cb.imsc.res.in/imppat/.
Journal of Medicinal Chemistry,
Год журнала:
2023,
Номер
66(8), С. 5377 - 5396
Опубликована: Апрель 5, 2023
We
have
analyzed
FDA-approved
macrocyclic
drugs,
clinical
candidates,
and
the
recent
literature
to
understand
how
macrocycles
are
used
in
drug
discovery.
Current
drugs
mainly
infectious
disease
oncology,
while
oncology
is
major
indication
for
candidates
Most
bind
targets
that
difficult
binding
sites.
Natural
products
provided
80–90%
of
whereas
ChEMBL
less
complex
structures.
Macrocycles
usually
reside
beyond
Rule
5
chemical
space,
but
30–40%
orally
bioavailable.
Simple
bi-descriptor
models,
i.e.,
HBD
≤
7
combination
with
either
MW
<
1000
Da
or
cLogP
>
2.5,
distinguished
orals
from
parenterals
can
be
as
filters
design.
propose
breakthroughs
conformational
analysis
inspiration
natural
will
further
improve
de
novo
design
macrocycles.
Nature,
Год журнала:
2023,
Номер
618(7963), С. 169 - 179
Опубликована: Май 24, 2023
Abstract
Target
occupancy
is
often
insufficient
to
elicit
biological
activity,
particularly
for
RNA,
compounded
by
the
longstanding
challenges
surrounding
molecular
recognition
of
RNA
structures
small
molecules.
Here
we
studied
patterns
between
a
natural-product-inspired
small-molecule
collection
and
three-dimensionally
folded
structures.
Mapping
these
interaction
landscapes
across
human
transcriptome
defined
structure–activity
relationships.
Although
RNA-binding
compounds
that
bind
functional
sites
were
expected
response,
most
identified
interactions
predicted
be
biologically
inert
as
they
elsewhere.
We
reasoned
that,
such
cases,
an
alternative
strategy
modulate
biology
cleave
target
through
ribonuclease-targeting
chimera,
where
molecule
appended
heterocycle
binds
locally
activates
RNase
L
1
.
Overlay
substrate
specificity
with
binding
landscape
molecules
revealed
many
favourable
candidate
binders
might
bioactive
when
converted
into
degraders.
provide
proof
concept,
designing
selective
degraders
precursor
disease-associated
microRNA-155
(pre-miR-155),
JUN
mRNA
MYC
mRNA.
Thus,
RNA-targeted
degradation
can
leveraged
convert
strong,
yet
inactive,
potent
specific
modulators
function.
JACS Au,
Год журнала:
2022,
Номер
2(11), С. 2400 - 2416
Опубликована: Окт. 14, 2022
The
case
for
a
renewed
focus
on
Nature
in
drug
discovery
is
reviewed;
not
terms
of
natural
product
screening,
but
how
and
why
biomimetic
molecules,
especially
those
produced
by
processes,
should
deliver
the
age
artificial
intelligence
screening
vast
collections
both
vitro
silico.
declining
product-likeness
licensed
drugs
consequent
physicochemical
implications
this
trend
context
current
practices
are
noted.
To
arrest
these
trends,
logic
seeking
new
bioactive
agents
with
enhanced
mimicry
considered;
notably
that
molecules
constructed
proteins
(enzymes)
more
likely
to
interact
other
(e.g.,
targets
transporters),
notion
validated
products.
Nature's
finite
number
building
blocks
their
interactions
necessarily
reduce
potential
numbers
structures,
yet
enable
expansion
chemical
space
inherent
diversity
physical
characteristics,
pertinent
property-based
design.
feasible
variations
motifs
considered
expanded
encompass
pseudo-natural
products,
leading
further
logical
step
harnessing
bioprocessing
routes
access
them.
Together,
offer
opportunities
enhancing
mimicry,
thereby
bringing
innovation
synthesis
exploiting
characteristics
recognition
processes.
computational
guidance
help
identifying
binding
commonalities
route
map
opportunity
design
tailored
"organic/biological"
rather
than
purely
"synthetic"
structures.
prototype
structures
pay
dividends
disposition
efficacy
while
inherently
enabling
greener
sustainable
manufacturing
techniques.
Molecular Informatics,
Год журнала:
2022,
Номер
41(11)
Опубликована: Авг. 2, 2022
Technological
advances
and
practical
applications
of
the
chemical
space
concept
in
drug
discovery,
natural
product
research,
other
research
areas
have
attracted
scientific
community's
attention.
The
large-
ultra-large
spaces
are
associated
with
significant
increase
number
compounds
that
can
potentially
be
made
exist
increasing
experimental
calculated
descriptors,
emerging
encode
molecular
structure
and/or
property
aspects
molecules.
Due
to
importance
continued
evolution
compound
libraries,
herein,
we
discuss
definitions
proposed
literature
for
emphasize
convenience,
discussed
use
complementary
descriptors
obtain
a
comprehensive
view
data
sets.
In
this
regard,
introduce
term
multiverse
refer
analysis
sets
through
several
spaces,
each
defined
by
different
set
representations.
is
contrasted
related
idea:
consensus
space.
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Ноя. 30, 2023
Targeted
proteasomal
and
autophagic
protein
degradation,
often
employing
bifunctional
modalities,
is
a
new
paradigm
for
modulation
of
function.
In
an
attempt
to
explore
degradation
by
means
autophagy
we
combine
arylidene-indolinones
reported
bind
the
autophagy-related
LC3B-protein
ligands
PDEδ
lipoprotein
chaperone,
BRD2/3/4-bromodomain
containing
proteins
BTK-
BLK
kinases.
Unexpectedly,
resulting
degraders
do
not
induce
macroautophagy,
but
instead
direct
their
targets
ubiquitin-proteasome
system.
Target
mechanism
identification
reveal
that
covalently
DCAF11,
substrate
receptor
in
CUL4A/B-RBX1-DDB1-DCAF11
E3
ligase.
The
tempered
α,
β-unsaturated
indolinone
electrophiles
define
drug-like
DCAF11-ligand
class
enables
exploration
this
ligase
chemical
biology
medicinal
chemistry
programs.
arylidene-indolinone
scaffold
frequently
occurs
natural
products
which
raises
question
whether
ligand
classes
can
be
found
more
widely
among
related
compounds.
Journal of Natural Products,
Год журнала:
2024,
Номер
87(7), С. 1844 - 1851
Опубликована: Июль 6, 2024
Natural
products
(NPs)
or
their
derivatives
represent
a
large
proportion
of
drugs
that
successfully
progress
through
clinical
trials
to
approval.
This
study
explores
the
presence
NPs
in
both
early-
and
late-stage
drug
discovery
determine
success
rate,
factors
features
natural
contribute
such
success.
As
proxy
for
early
development
stages,
we
analyzed
patent
applications
over
several
decades,
finding
consistent
NP,
NP-derived,
synthetic-compound-based
documents,
with
latter
group
outnumbering
NP
NP-derived
ones
(approximately
77%
vs
23%).
We
next
assessed
trial
data,
where
observed
steady
increase
compounds
from
phases
I
III
(from
approximately
35%
phase
45%
III),
an
inverse
trend
synthetics
65%
55%
III).
Finally,
vitro
silico
toxicity
studies
revealed
were
less
toxic
alternatives
synthetic
counterparts.
These
discoveries
offer
valuable
insights
successful
NP-based
development,
highlighting
potential
benefits
prioritizing
as
starting
points.